)
Suven Life Sciences today reported a 16.68% increase in its net profit at Rs 34.74 crore for the first quarter ended June 30, 2014.
The company had posted a net profit of Rs 29.77 crore in the corresponding quarter last fiscal, Suven Life Sciences said in a filing to BSE.
Net sales during the period under review stood at Rs 141.53 crore as against Rs 108.67 crore, up 30.23%.
During the quarter, revenue from contract research and manufacturing services (CRAMS) stood at Rs 138.95 crore as compared to Rs 106.89 crore in the year-ago period.
On the other hand, income from drug discovery, development and support services stood at Rs 2.58 crore as against Rs 1.78 crore in Q1 last fiscal, the company said.
Suven's major thrust on innovative R&D in drug discovery continues with a spending of Rs 8.9 crore, which is 6.28% of revenue for the quarter ended June 30, 2014, it added.
Shares of Suven Life Sciences were trading at Rs 123.15 per scrip in the morning trade, down 0.28% from the previous close on BSE.
